Cancer Letters
Volume 241, Issue 1 , Pages 59-63 , 8 September 2006

Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population

  • Yasuo Awakura

      Affiliations

    • Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Noriyuki Ito

      Affiliations

    • Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Eijiro Nakamura

      Affiliations

    • Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Takeshi Takahashi

      Affiliations

    • Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Hirokazu Kotani

      Affiliations

    • Laboratory of Anatomic Pathology, Kyoto University Hospital, Kyoto, Japan
    • ,
  • Yoshiki Mikami

      Affiliations

    • Laboratory of Anatomic Pathology, Kyoto University Hospital, Kyoto, Japan
    • ,
  • Toshiyuki Manabe

      Affiliations

    • Laboratory of Anatomic Pathology, Kyoto University Hospital, Kyoto, Japan
    • ,
  • Toshiyuki Kamoto

      Affiliations

    • Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Tomonori Habuchi

      Affiliations

    • Department of Urology, Akita University School of Medicine, Akita, Japan
    • ,
  • Osamu Ogawa

      Affiliations

    • Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 75 751 3325; fax: +81 75 761 3441.

Received 27 August 2005 ,Revised 29 September 2005 ,Accepted 7 October 2005.

References 

  1. Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. Br. J. Urol. Int. 2000;86:20–27
  2. Ajiki W, Tsukuma H, Oshima A. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn. J. Clin. Oncol. 2004;34:352–356
  3. Chow WH, Devesa SS, Warren JL, Fraumeni F. Rising incidence of renal cell cancer in the United States. J. Am. Med. Assoc. 1999;281:1628–1631
  4. Ozdemir E, Kakehi Y, Nakamura E, Kinoshita H, Terachi T, Okada Y, et al. HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma. Cancer Res. 1997;57:742–746
  5. Nakamura E, Megumi Y, Kobayashi T, Kamoto T, Ishitoya S, Terachi T, et al. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin. Cancer Res. 2002;8:2620–2625
  6. Siegsmund M, Brinkmann U, Schaffeler E, Weirich G, Schwab M, Eichelbaum M. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J. Am. Soc. Nephrol. 2002;13:1847–1854
  7. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoda Y. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int. J. Cancer. 2003;106:372–374
  8. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2002;2:161–174
  9. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin. Cancer Res. 2002;8:3820–3823
  10. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, et al. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res. 2002;62:6430–6433
  11. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross S. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Res. 2001;7:3113–3119
  12. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000;103:481–490
  13. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2–13.1. Hum. Genet. 1999;105:418–423
  14. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick G, et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:987–989
  15. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:992–993
  16. Goldstein NS. Grading of renal cell carcinoma. Urol. Clin. North Am. 1999;26:637–642
  17. Morgan AR, Zhang B, Tapper W, Collins A, Ye S. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J. Mol. Med. 2003;81:321–326
  18. Mejean A, Oudard S, Thiounn N. Prognostic factors of renal cell carcinoma. J. Urol. 2003;169:821–827
  19. Yamada Y, Ando F, Niino N, Shimokata H. Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men. Metabolism. 2004;53:135–137
  20. Kim JS, Park HY, Kwon JH, Im EK, Choi DH, Jang S, et al. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med. J. 2002;43:473–481
  21. Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J. Cancer Res. Clin. Oncol. 2005;131:19–25
  22. Masuda H, Kurita Y, Suzuki A, Kanbayashi T, Suzuki K, Fujita K. Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases. Int. J. Urol. 1997;4:247–253
  23. Onodera Y, Matsuda N, Ohta M, Goto R, Fujii N, Yamada Y. Prognostic significance of tumor grade for renal cell carcinoma. Int. J. Urol. 2000;7:4–9

PII: S0304-3835(05)00914-6

doi: 10.1016/j.canlet.2005.10.005

Cancer Letters
Volume 241, Issue 1 , Pages 59-63 , 8 September 2006

Article Tools

* Image Usage & Resolution